Stay updated on Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, indicating a site/version refresh rather than a change to the clinical study information.
    Difference
    0.1%
    Check dated 2026-04-24T05:39:14.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:33.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    - Version history updated: added revision v3.5.0 and removed revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:58:47.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Footer/revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:55:12.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the government funding lapse notice as well as Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T11:37:35.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Added a funding/operational status notice at the top of the page and updated the revision tag from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:15:17.000Z thumbnail image

Stay in the know with updates to Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.